Chandigarh, Oct 7: The Punjab government has issued an immediate ban on the sale, distribution, and use of Coldrif cough syrup following the deaths of 14 children in Madhya Pradesh, allegedly linked to the contaminated medicine.

An order from the Food and Drugs Administration (FDA), Punjab, stated that the drug, batch number SR-13, manufactured by Sresan Pharmaceutical in Tamil Nadu, was declared “not of standard quality” by the government analyst and FDA, Madhya Pradesh. Tests revealed that the syrup contains Diethylene Glycol (46.28% w/v), a highly toxic substance harmful to health.

The FDA order directed all retailers, distributors, medical practitioners, hospitals, and healthcare institutions in Punjab to immediately stop purchasing, selling, or using the syrup. Authorities have also

See Full Page